Rigel
corporate overview

pipeline

investors & media

careers



 press release archive

press release archive

Current | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997


12/11/2001 Rigel Files Shelf Registration Statement
11/28/2001 Rigel Announces Milestone Payment from Pfizer for Validated Target for Respiratory Drug Development
11/7/2001 Rigel Reports Third Quarter 2001 Financial Results
10/29/2001 Rigel Announces Executive Appointments and Promotions
10/11/2001 Rigel Discusses Two Lead Product Candidates at UBS Warburg Conference
10/2/2001 Rigel and Evotec OAI Enter Into Medicinal Chemistry Agreement to Indentify a New Class of Anti-Cancer Compounds Called Ubiquitin Ligase Inhibitors
9/5/2001 MediChem Life Sciences and Rigel Pharmaceuticals Enter into Structural Proteomics Agreement Focused on Ubiquitin Ligases
8/8/2001 Rigel Reports Second Quarter 2001 Financial Results
7/31/2001 Rigel and Novartis Initiate Oncology Drug Discovery Collaboration
5/31/2001 Rigel Accelerates Asthma/Allergy Program Through Agreement with Albany Molecular Research
5/8/2001 Rigel Reports First Quarter 2001 Financial Results
5/1/2001 Rigel Demonstrates Success of its Proprietary Fluorescent Libraries in Human Functional Genomic Screens
3/23/2001 Rigel to Present at New York Society of Securities Analysts Healthcare Conference
2/7/2001 Rigel Reports Fourth Quarter and Year 2000 Financial Results
1/30/2001 Rigel Names Gregory S. Wagner, Ph.D. to Head Preclinical Development Activities
1/25/2001 Rigel Announces Extension of Asthma/Allergy Drug Discovery Collaboration with Pfizer
1/15/2001 Rigel and Pfizer Amend Deadline Date on Option to Renew Asthma/Allergy Drug Discovery Collaboration
© 2013 Rigel  |  privacy  |  disclaimer | Follow Us On:    contact us  |  site map  |  search    Search